49.46 USD
+0.32 (+0.65%)
49.55 USD
+0.09 (+0.18%)
BRKR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. While BRKR is still in line with the averages on profitability rating, there are concerns on its financial health. BRKR is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- BRKR had positive earnings in the past year.
- BRKR had a positive operating cash flow in the past year.
- Each year in the past 5 years BRKR has been profitable.
- BRKR had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- BRKR's Return On Assets of -0.37% is fine compared to the rest of the industry. BRKR outperforms 64.91% of its industry peers.
- Looking at the Return On Equity, with a value of -0.97%, BRKR is in the better half of the industry, outperforming 64.91% of the companies in the same industry.
- BRKR has a better Return On Invested Capital (4.01%) than 68.42% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for BRKR is below the industry average of 13.75%.
- The 3 year average ROIC (9.30%) for BRKR is well above the current ROIC(4.01%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROIC | 4.01% |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
1.3 Margins
- BRKR's Profit Margin has declined in the last couple of years.
- BRKR has a better Operating Margin (8.99%) than 66.67% of its industry peers.
- In the last couple of years the Operating Margin of BRKR has declined.
- With a Gross Margin value of 48.00%, BRKR perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
- In the last couple of years the Gross Margin of BRKR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% |
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKR is destroying value.
- BRKR has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, BRKR has less shares outstanding
- BRKR has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.53 indicates that BRKR is not a great score, but indicates only limited risk for bankruptcy at the moment.
- BRKR has a Altman-Z score (2.53) which is in line with its industry peers.
- BRKR has a Debt/Equity ratio of 0.82. This is a neutral value indicating BRKR is somewhat dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.82, BRKR is doing worse than 75.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.53 |
ROIC/WACC0.39
WACC10.16%
2.3 Liquidity
- A Current Ratio of 1.85 indicates that BRKR should not have too much problems paying its short term obligations.
- The Current ratio of BRKR (1.85) is worse than 61.40% of its industry peers.
- BRKR has a Quick Ratio of 1.85. This is a bad value and indicates that BRKR is not financially healthy enough and could expect problems in meeting its short term obligations.
- The Quick ratio of BRKR (0.89) is worse than 84.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 |
3. Growth
3.1 Past
- BRKR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.37%.
- BRKR shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.95% yearly.
- The Revenue has been growing slightly by 6.10% in the past year.
- BRKR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.19% yearly.
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
3.2 Future
- BRKR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.58% yearly.
- Based on estimates for the next years, BRKR will show a small growth in Revenue. The Revenue will grow by 3.38% on average per year.
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 24.73, the valuation of BRKR can be described as rather expensive.
- Based on the Price/Earnings ratio, BRKR is valued cheaply inside the industry as 82.46% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of BRKR to the average of the S&P500 Index (27.54), we can say BRKR is valued inline with the index average.
- A Price/Forward Earnings ratio of 22.69 indicates a rather expensive valuation of BRKR.
- 82.46% of the companies in the same industry are more expensive than BRKR, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.31, BRKR is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.73 | ||
| Fwd PE | 22.69 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 84.21% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17.52 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)2.76
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.38%, BRKR is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.09, BRKR pays a better dividend. On top of this BRKR pays more dividend than 89.47% of the companies listed in the same industry.
- With a Dividend Yield of 0.38, BRKR pays less dividend than the S&P500 average, which is at 1.92.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
5.2 History
- The dividend of BRKR has a limited annual growth rate of 4.81%.
- BRKR has paid a dividend for at least 10 years, which is a reliable track record.
- BRKR has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)4.81%
Div Incr Years0
Div Non Decr Years8
5.3 Sustainability
- BRKR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
- BRKR's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP-96.62%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
49.46
+0.32 (+0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-03 2025-11-03/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners90.2%
Inst Owner Change0.06%
Ins Owners26.95%
Ins Owner Change0.17%
Market Cap7.51B
Revenue(TTM)3.44B
Net Income(TTM)-23.70M
Analysts79.09
Price Target51.65 (4.43%)
Short Float %11.12%
Short Ratio4.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
Yearly Dividend0.2
Dividend Growth(5Y)4.81%
DP-96.62%
Div Incr Years0
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.84%
Min EPS beat(2)-26.01%
Max EPS beat(2)31.69%
EPS beat(4)3
Avg EPS beat(4)3.35%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)5
Avg EPS beat(8)4.64%
EPS beat(12)9
Avg EPS beat(12)5.65%
EPS beat(16)11
Avg EPS beat(16)6.13%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.65%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-0.53%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)6
Avg Revenue beat(12)0.67%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)8.84%
PT rev (3m)12.88%
EPS NQ rev (1m)-0.26%
EPS NQ rev (3m)-24.3%
EPS NY rev (1m)0.27%
EPS NY rev (3m)-4.48%
Revenue NQ rev (1m)-0.1%
Revenue NQ rev (3m)-3.88%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.73 | ||
| Fwd PE | 22.69 | ||
| P/S | 2.19 | ||
| P/FCF | N/A | ||
| P/OCF | 79.69 | ||
| P/B | 3.09 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.52 |
EPS(TTM)2
EY4.04%
EPS(NY)2.18
Fwd EY4.41%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.62
OCFY1.25%
SpS22.63
BVpS16.01
TBVpS-0.24
PEG (NY)N/A
PEG (5Y)2.76
Graham Number26.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.37% | ||
| ROE | -0.97% | ||
| ROCE | 5.98% | ||
| ROIC | 4.01% | ||
| ROICexc | 4.25% | ||
| ROICexgc | 8.62% | ||
| OM | 8.99% | ||
| PM (TTM) | N/A | ||
| GM | 48% | ||
| FCFM | N/A |
ROA(3y)6.74%
ROA(5y)6.6%
ROE(3y)21.33%
ROE(5y)21.26%
ROIC(3y)9.3%
ROIC(5y)9.28%
ROICexc(3y)11.26%
ROICexc(5y)12.82%
ROICexgc(3y)18.89%
ROICexgc(5y)20.78%
ROCE(3y)13.86%
ROCE(5y)13.83%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-9.61%
ROICexc growth 3Y-31.42%
ROICexc growth 5Y-15.9%
OM growth 3Y-13.3%
OM growth 5Y-4.84%
PM growth 3Y-33.57%
PM growth 5Y-18.8%
GM growth 3Y-0.46%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.82 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 3.79 | ||
| Cap/Depr | 48.77% | ||
| Cap/Sales | 3.05% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 17.99% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 0.89 | ||
| Altman-Z | 2.53 |
F-Score5
WACC10.16%
ROIC/WACC0.39
Cap/Depr(3y)100.42%
Cap/Depr(5y)105.08%
Cap/Sales(3y)4.05%
Cap/Sales(5y)4.17%
Profit Quality(3y)75.38%
Profit Quality(5y)88.75%
High Growth Momentum
Growth
EPS 1Y (TTM)-18.37%
EPS 3Y4.7%
EPS 5Y8.95%
EPS Q2Q%-25%
EPS Next Y-20.53%
EPS Next 2Y-4.9%
EPS Next 3Y1.14%
EPS Next 5Y5.58%
Revenue 1Y (TTM)6.1%
Revenue growth 3Y11.66%
Revenue growth 5Y10.19%
Sales Q2Q%-0.45%
Revenue Next Year1.9%
Revenue Next 2Y1.7%
Revenue Next 3Y2.71%
Revenue Next 5Y3.38%
EBIT growth 1Y-16.55%
EBIT growth 3Y-3.19%
EBIT growth 5Y4.86%
EBIT Next Year9.99%
EBIT Next 3Y11.38%
EBIT Next 5Y10.68%
FCF growth 1Y-105.14%
FCF growth 3Y-10.61%
FCF growth 5Y-0.63%
OCF growth 1Y-70.17%
OCF growth 3Y-3.81%
OCF growth 5Y3.32%
BRUKER CORP / BRKR FAQ
Can you provide the ChartMill fundamental rating for BRUKER CORP?
ChartMill assigns a fundamental rating of 4 / 10 to BRKR.
What is the valuation status for BRKR stock?
ChartMill assigns a valuation rating of 3 / 10 to BRUKER CORP (BRKR). This can be considered as Overvalued.
Can you provide the profitability details for BRUKER CORP?
BRUKER CORP (BRKR) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for BRKR stock?
The Price/Earnings (PE) ratio for BRUKER CORP (BRKR) is 24.73 and the Price/Book (PB) ratio is 3.09.
What is the financial health of BRUKER CORP (BRKR) stock?
The financial health rating of BRUKER CORP (BRKR) is 2 / 10.